CD8A and neoplasm: Tumor-reactive T cells (pTRT) vary in different tumor microenvironments, with CD8+ T cells mainly switching in natural killer (NK)-like T cells and terminal exhausted T cells, CD8+ Treg cells, and type 17 CD8+ T cells (121).